期刊文献+

泪液标志物在系统性疾病中的研究进展 被引量:3

Recent progression on tear fluid markers in systemic disease
下载PDF
导出
摘要 泪液是主要由泪腺分泌的一种水样液体,是眼表的一种成分复杂的体液,可能含有数千种蛋白质及其他分子,研究已证实这些成分的改变在眼病的发生和发展中具有重要作用。泪液成分包括蛋白质、脂质及代谢物等,容易获取,不仅可以用于生物标志物,还可用于研究眼科系统性疾病的发病过程。通过测定泪液成分的变化,可能用来确定疾病发展的关键通路,为预防及治疗提供了一种新的可能。本文将到目前为止尚未确定的泪液标志物在眼科系统性疾病的应用做一简要综述。 Tear is a complex fluid mainly secreted by lacrimal gland.It is a complex body fluid,which may contain thousands of protein/peptides and other molecules.Studies have determined that the changes in the chemical compositions of tears play an important role in some diseases and their progression.Tear components including protein,lipid and metabolites,which is easy to be obtained,not only can be used for biomarkers,can also be used to study an eye the onset of systemic disease process.Measuring the changes in composition of tear may be used to determine the critical path of the disease development,provide a new possibility for prevention and treatment.This article reviews the ophthalmic applications of tear markers in the systemic disease,which has not been determined so far.
出处 《眼科新进展》 CAS 北大核心 2017年第8期780-784,共5页 Recent Advances in Ophthalmology
基金 国家自然科学基金资助(编号:81160118 81460092 81400372 81660158) 江西省远航工程(编号:2014022) 江西省自然科学基金重大项目(编号:20161ACB21017) 江西省自然科学基金(编号:20151BAB215016) 江西省科技支撑计划项目(编号:20151BBG70223)~~
关键词 生物标志物 泪液 眼科疾病 系统性疾病 biomarkers tear fluid eye disease systemic disease
  • 相关文献

参考文献2

二级参考文献31

  • 1王伟,李筱荣,袁佳琴.2型糖尿病患者角膜基质细胞形态学特征的共焦显微镜观察[J].眼科研究,2007,25(1):64-67. 被引量:4
  • 2张承芬.眼部病学[M].北京:人民卫生出版社,1998.243.
  • 3罗向霞,段俊国,刘文舟,吴艳乔.糖尿病视网膜病变相关危险因素分析[J].眼科研究,2007,25(8):599-601. 被引量:15
  • 4Saw SM, Foster P J, Gazzard G, Seah S. Causes of blindness, low vision, and questionnaire-assessed poor visual function in Singaporean Chinese adults :The Tanjong Pagar survey [ J ]. Ophthalmology,2004,111 (5) :1151-1158.
  • 5Klein R, Klein BE, Moss SE, Wong TY. Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI:the Wisconsin epidemiologic study of diabetic retinopathy [J].Ophthalmology,2007,114(10) : 1884-1892.
  • 6Sandbaek A, Griffin S J, Rutten G, Davies M, Stolk R, Khunti K, et al. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study [ J ]. Diabetologia,2008,51 (7) : 1127 - 1134.
  • 7Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S ,Bellary S ,et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study [ J ]. Diabetes Care.2009.32 ( 3 ) :410-415.
  • 8Ngarmukos C, Bunnag P, Kosachunhanun N, Krittiyawong S, Leelawatana R,Prathipanawatr T ,et al. Thailand diabetes registry project :prevalence, characteristics and treatment of patients with diabetic nephropathy[J]. J Med Assoc Thai,2005,89 ( 1 ) : S37-42.
  • 9Wang Y, Flores L, Lu S, Miao H, Li YS, Chien S. Shear stress regulates the Flk-1/Cbl/PI3K/NF-KB pathway via actin and tyrosine kinases [ J ]. Cell Mol Bioeng, 2009,2 ( 3 ) : 341-350.
  • 10Mattix H J, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria, implications of sex and race [ J ]. J Am Soc Nephrol,2002,13 (4) : 1034-1039.

共引文献78

同被引文献16

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部